Related Experiment Video
Updated: Mar 6, 2026
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
A fatal Clostridium perfringens infection with hemolysis after chemotherapy in an adolescent
Musa G Kukul1, Kısmet Ciki1, Eda Karadag-Oncel2
1Department of Pediatrics, Faculty of Medicine, Hacettepe University.
Abstract:
Gas gangrene, clostridial myonecrosis, is one of the most serious infectious diseases, characterized by rapidly progressive destruction of deep soft tissues and production of gas within the tissues. We presented a case of fatal spontaneous gas gangrene due to Clostridium perfringens in a patient with acute lymphoblastic leukemia during remission induction chemotherapy phase.
Insights
Gas gangrene, a severe infection, rapidly destroys tissue and produces gas. This case highlights a fatal spontaneous Clostridium perfringens infection in an acute lymphoblastic leukemia patient undergoing chemotherapy.
Area of Science:
- Infectious Diseases
- Hematology
- Oncology
Background:
- Gas gangrene (clostridial myonecrosis) is a severe, rapidly progressing soft tissue infection.
- Patients with hematologic malignancies undergoing chemotherapy are at increased risk for infections.
- Acute lymphoblastic leukemia (ALL) treatment involves intensive immunosuppression.
Observation:
- A case of fatal, spontaneous gas gangrene is presented.
- The infection was caused by Clostridium perfringens.
- The patient had acute lymphoblastic leukemia in remission during induction chemotherapy.
Findings:
- Clostridium perfringens caused a fatal spontaneous gas gangrene.
- The patient was undergoing remission induction chemotherapy for ALL.
- This highlights a rare but severe complication in immunocompromised patients.
Implications:
- Early recognition and management of gas gangrene are crucial, especially in immunocompromised hosts.
- This case underscores the potential for severe infections during ALL treatment.
- Further research into preventative strategies for infectious complications in leukemia patients is warranted.
